Literature DB >> 8591827

Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects--evidence against a modulating role for insulin.

V Mohamed-Ali1, M M Gould, S Gillies, S Goubet, J S Yudkin, A P Haines.   

Abstract

Elevated concentrations of proinsulin-like molecules, other than insulin, may be associated with abnormalities of cardiovascular risk factors, promoting atherogenesis and thrombosis. Using specific assays we examined the relationship of levels of insulin, intact proinsulin and des-31,32 proinsulin to blood pressure, lipids, fibrinogen, factor VII and albumin excretion rate in 270 europids with normal glucose tolerance. After correcting for age and body mass index, fasting and 2-h insulin concentrations were significantly associated with those of total and LDL-cholesterol (r = 0.18-0.22), HDL-cholesterol (both r = -0.20) and triglycerides (r = 0.21 and 0.18), but not with blood pressure. Concentrations of intact and des-31,32 proinsulin showed significant associations with those of total and LDL-cholesterol (r = 0.20-0.23), HDL-cholesterol (r = -0.31 and -0.32) and triglycerides (r = 0.22 and 0.26). Fasting insulin and intact proinsulin concentrations were significantly associated with fibrinogen (r = -0.15 and 0.18). Concentrations of proinsulin-like molecules comprised less than 10% of all insulin-like molecules, and so were calculated not to influence previously described relationships between insulin concentrations and cardiovascular risk factors measured using non-specific assays. In multiple regression analyses des-31,32 proinsulin concentration was more strongly associated with those of HDL-cholesterol (negatively), LDL-cholesterol and triglycerides than fasting insulin concentrations, while intact proinsulin replaced insulin concentrations in their relationships with fibrinogen. Our results show correlations between dyslipidaemia and proinsulin-like molecules at concentrations at which biological, insulin-like, activity appears unlikely. We also show relationships between LDL-cholesterol and fibrinogen and the proinsulin-like molecules.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8591827     DOI: 10.1007/bf00402183

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  Microalbuminuria and associated cardiovascular risk factors in the community.

Authors:  P H Winocour; J O Harland; J P Millar; M F Laker; K G Alberti
Journal:  Atherosclerosis       Date:  1992-03       Impact factor: 5.162

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Rapid, competitive enzymoimmunoassay for albumin in urine.

Authors:  J Chesham; S W Anderton; C F Kingdon
Journal:  Clin Chem       Date:  1986-04       Impact factor: 8.327

4.  Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men.

Authors:  R W Bergstrom; L L Newell-Morris; D L Leonetti; W P Shuman; P W Wahl; W Y Fujimoto
Journal:  Diabetes       Date:  1990-01       Impact factor: 9.461

5.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.

Authors:  W J Sobey; S F Beer; C A Carrington; P M Clark; B H Frank; I P Gray; S D Luzio; D R Owens; A E Schneider; K Siddle
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

6.  Insulin resistance in insulin-dependent diabetic patients with microalbuminuria.

Authors:  J Yip; M B Mattock; A Morocutti; M Sethi; R Trevisan; G Viberti
Journal:  Lancet       Date:  1993-10-09       Impact factor: 79.321

7.  Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia.

Authors:  W H Sheu; S M Shieh; M M Fuh; D D Shen; C Y Jeng; Y D Chen; G M Reaven
Journal:  Arterioscler Thromb       Date:  1993-03

8.  Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study.

Authors:  M Modan; H Halkin; A Lusky; P Segal; Z Fuchs; A Chetrit
Journal:  Arteriosclerosis       Date:  1988 May-Jun

9.  Plasma insulin and lipoprotein concentrations: an atherogenic association?

Authors:  T J Orchard; D J Becker; M Bates; L H Kuller; A L Drash
Journal:  Am J Epidemiol       Date:  1983-09       Impact factor: 4.897

Review 10.  Circulating proinsulin-like molecules.

Authors:  J S Yudkin
Journal:  J Diabetes Complications       Date:  1993 Apr-Jun       Impact factor: 2.852

View more
  4 in total

1.  Proinsulin and insulin responses to a mixed meal in hypertriglyceridaemic men.

Authors:  R Gama; F Norris; S Hampton; L Morgan; J Wright; V Marks
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

2.  The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  C C Lee; C Lorenzo; S M Haffner; L E Wagenknecht; A Festa; M O Goodarzi; D Stefanovski; N C Olson; J M Norris; M J Rewers; A J Hanley
Journal:  Diabetologia       Date:  2012-10-10       Impact factor: 10.122

Review 3.  Insulin resistance and the metabolic syndrome--or the pitfalls of epidemiology.

Authors:  J S Yudkin
Journal:  Diabetologia       Date:  2007-06-26       Impact factor: 10.122

4.  Proinsulin:insulin and insulin:glucose ratios as predictors of carotid plaque growth: a population-based 7 year follow-up of the Tromsø Study.

Authors:  J Kronborg; S H Johnsen; I Njølstad; I Toft; B O Eriksen; T Jenssen
Journal:  Diabetologia       Date:  2007-06-09       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.